SCHEMBL19081840

SCHEMBL19081840

c1cc(-c2ccc3ccccc3c2)cc(-c2c3ccccc3c(-c3ccc4c(c3)sc3ccc5oc6ccc7ccccc7c6c5c34)c3ccccc23)c1

nearest known ligand 0.36

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ABCG2 Q9UNQ0 7/20 0.36
CYP1A1 P04798 2/20 0.36
AHR P35869 2/20 0.36
PAX8 Q06710 2/20 0.36
CYP1A2 P05177 1/20 0.36
FYN P06241 1/20 0.36
MAPK3 P27361 1/20 0.36
CYP1B1 Q16678 1/20 0.34
NPC1 O15118 2/20 0.33
TDP1 Q9NUW8 2/20 0.33
HSD17B1 P14061 1/20 0.33
HSD17B2 P37059 1/20 0.33
RAB9A P51151 1/20 0.33
LIMK1 P53667 1/20 0.32
LIMK2 P53671 1/20 0.32
F9 P00740 1/20 0.31
S1PR4 O95977 1/20 0.31
S1PR5 Q9H228 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19081986 0.91 ABCG2 (0.36) ABCG2CYP1A1AHRPAX8CYP1A2
SCHEMBL19082169 0.91 HSD17B1 (0.38) CYP1A1CYP1A2CYP1B1HSD17B1HSD17B2
SCHEMBL19082309 0.91 HSD17B1 (0.38) CYP1A1CYP1A2CYP1B1HSD17B1HSD17B2
SCHEMBL17944362 0.90 HSD17B1 (0.39) CYP1A1CYP1A2CYP1B1HSD17B1HSD17B2
SCHEMBL17943957 0.90 HSD17B1 (0.39) CYP1A1CYP1A2CYP1B1HSD17B1HSD17B2
SCHEMBL19081839 0.89 CYP1A1 (0.36) ABCG2CYP1A1AHRPAX8CYP1A2
SCHEMBL19081985 0.89 CYP1A1 (0.36) ABCG2CYP1A1AHRPAX8CYP1A2
SCHEMBL17945499 0.87 HSD17B1 (0.39) CYP1A1CYP1A2CYP1B1TDP1HSD17B1
SCHEMBL17945717 0.87 HSD17B1 (0.39) CYP1A1CYP1A2CYP1B1TDP1HSD17B1
SCHEMBL19081984 0.87 LIMK1 (0.36) ABCG2CYP1A1AHRPAX8CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2020-02-04 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same CRY1, CRY2, CCNT1 ABCG2 4823/4885CYP1A1 184/4885AHR 2453/4885
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNT1 ABCG2 4823/4885CYP1A1 184/4885AHR 2453/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.